The Effects of p-nonylphenol on the Myometrial Contractile Activity

dc.contributor.authorOzatik, F. Yasemin
dc.contributor.authorKaygisiz, B.
dc.contributor.authorErol, K.
dc.contributor.authorDundar, Y.
dc.contributor.authorOnkol, T.
dc.contributor.authorSahin, M. F.
dc.date.accessioned2026-02-06T18:43:52Z
dc.date.issued2015
dc.departmentDoğu Akdeniz Üniversitesi
dc.description.abstractWe aimed to investigate the effects and mechanisms of action of p-nonylphenol(p-NP) on uterine contractility in rats. The uterine tissues of female Sprague Dawley rats in diestrus were bathed in isolated organ bath. The effects of vehicle alone (0.1% ethanol), the positive control 17--E-2 (10(-5) M) and p-NP (10(-9) M, 10(-8) M, 10(-7) M, 10(-6) M) on spontaneous and KCl-induced uterine contractility of rats were studied. Also, the effects of p-NP in combination with actinomycin D (10(-5) M) (gene transcription inhibitor), cycloheximide (10(-4) M) (protein synthesis inhibitor), fulvestrant (10(-6) M) (pure estrogen receptor antagonist), 2-hydroxy-5-nonanoylbenzamide (10(-3) M) (compound 1b, anti-uterotrophic compound) on spontaneous uterine contractions, and with propranolol (20 mu M) (-adrenoceptor antagonist) and noradrenaline (5 mu M) on KCl (40mM) induced contractions were investigated. p-NP exhibited a concentration-dependent inhibition on spontaneous uterine contractions. There was no significant difference between the highest p-NP concentration (10(-6) M) and the positive control 17--E-2 in terms of % inhibition (p>0.05). The inhibitory effect of p-NP (10(-6) M) on spontaneous contractions was blocked by actinomycin D (p<0.001), cycloheximide (p<0.001), fulvestrant (p<0.001) and compound 1b (p<0.001). 17--E-2 (10(-5) M) exerted a higher inhibition % on KCl induced contractions than p-NP (10(-6) M). The relaxant effect of p-NP on KCl-induced uterine contractions was inhibited by noradrenaline (p<0.05) but not by propranolol (p>0.05). We suggest that p-NP inhibited uterine contractions similar as 17--E-2 and genomic pathways are involved and -adrenoceptors might modulate the activity of p-NP. In addition, compound 1b showed an uterotonic activity and reversed the effect of p-NP.
dc.identifier.doi10.1055/s-0034-1387717
dc.identifier.endpage392
dc.identifier.issn2194-9379
dc.identifier.issn2194-9387
dc.identifier.issue7
dc.identifier.orcid0000-0002-8422-2975
dc.identifier.pmid25162503
dc.identifier.scopus2-s2.0-84936996362
dc.identifier.scopusqualityQ3
dc.identifier.startpage388
dc.identifier.urihttps://doi.org/10.1055/s-0034-1387717
dc.identifier.urihttps://hdl.handle.net/11129/13783
dc.identifier.volume65
dc.identifier.wosWOS:000357868400009
dc.identifier.wosqualityQ3
dc.indekslendigikaynakWeb of Science
dc.indekslendigikaynakPubMed
dc.indekslendigikaynakScopus
dc.language.isoen
dc.publisherGeorg Thieme Verlag Kg
dc.relation.ispartofDrug Research
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı
dc.rightsinfo:eu-repo/semantics/closedAccess
dc.snmzKA_WoS_20260204
dc.subject2-hydroxy-5-nonanoylbenzamide
dc.subjectisolated organ bath
dc.subjectp-nonylphenol
dc.subjectuterine contractility
dc.titleThe Effects of p-nonylphenol on the Myometrial Contractile Activity
dc.typeArticle

Files